NeuroMetrix Corporation (NURO): Market Capitalization-to-Revenue Ratio

NeuroMetrix, Inc. (NURO) generates revenue through the sale of neurostimulation systems and rapid nerve diagnostics for diabetes. The company's price/sales multiple clearly compares the business's market value to its revenue, and the current figure is 3.10. Currently, the company maintains a compact engineering staff, minimizing employee turnover. The recruitment of bioengineers is based on an empathetic culture and an expanded benefits package aimed at improving patient lives.

NeuroMetrix, Inc. (NURO) investments in a highly skilled engineering team to develop pain management systems are building the company's long-term intellectual capital. By analyzing the price-to-sales multiple, an investor assesses the market value of the business relative to its annual revenue, which allows them to filter out price noise and determine the fair value of assets based on the price action reflected in this chart.